ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1,2,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
3,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,4,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
4,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
5,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
5,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
6,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
7,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
9,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
10,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
11,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
11,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
12,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
12,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
13,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
13,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
13,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
14,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
14,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
15,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
16,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
18,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
19,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
21,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
22,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
23,1,Wolff-Parkinson-White syndrome,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
24,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
24,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
27,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
27,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
28,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
29,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
29,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
29,4,Thought blocking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
30,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
31,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
31,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
31,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
31,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
32,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
32,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
33,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
34,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
39,1,Aortic valve sclerosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
39,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
39,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,5,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,6,Complication of delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
39,7,Congenital anomaly in offspring,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
39,8,Congenital heart valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
39,9,Congenital pulmonary valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
39,10,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,11,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
39,12,Maternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
39,13,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,14,Neonatal respiratory arrest,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
39,15,Pulmonary valve sclerosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
39,16,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
39,17,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
40,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
41,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
41,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
43,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
44,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
44,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
46,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
47,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
47,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
48,1,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
48,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
48,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
49,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
51,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
51,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
51,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
51,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
51,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
52,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
53,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
53,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
54,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
54,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
54,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
54,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
54,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
55,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
55,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
56,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
56,2,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
57,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
57,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
58,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
58,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
58,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
59,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
59,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
59,3,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
59,4,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
59,5,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
59,6,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
59,7,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
59,8,Cloacal exstrophy,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
59,9,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
59,10,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
59,11,Congenital genital malformation,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
59,12,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
59,13,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
59,14,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
59,15,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,16,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,17,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,18,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
59,19,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
59,20,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,21,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,22,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
59,23,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
59,24,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
59,25,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
59,26,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
59,27,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
59,28,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
59,29,Musculoskeletal deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
59,30,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,31,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
59,32,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
59,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,34,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,35,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
59,36,Tethered cord syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
59,37,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
59,38,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
60,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
60,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
61,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
61,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
62,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
62,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
62,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
62,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
63,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
63,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
65,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
67,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
67,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
67,3,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
68,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
69,1,Central nervous system viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
69,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
71,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
71,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
73,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
73,2,Ejaculation delayed,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
74,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
74,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
75,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
75,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
76,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
76,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
77,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
78,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,2,Meralgia paraesthetica,Mononeuropathies,Peripheral neuropathies,Nerv,N
78,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
79,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
80,1,Blood corticotrophin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
80,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
80,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
81,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
81,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
83,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
83,2,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
83,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
83,4,Renal tubular dysfunction,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
84,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
84,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
84,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
85,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
85,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
87,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
87,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
88,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
88,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
88,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
88,5,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
88,6,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
88,7,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
88,8,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
88,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
89,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
89,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
89,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
90,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
91,1,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
92,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
93,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
93,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
93,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,5,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
94,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
94,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
95,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
95,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
95,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
96,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
97,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
97,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
97,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
98,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
99,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
99,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
100,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
101,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
101,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
101,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
102,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
102,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
103,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
103,2,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
103,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
103,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
103,5,Headache,Headaches NEC,Headaches,Nerv,N
103,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
103,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
103,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
103,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
104,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
104,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
105,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
105,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
105,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
106,1,Headache,Headaches NEC,Headaches,Nerv,N
106,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,N
107,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
108,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
108,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
108,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
108,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
108,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
108,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
109,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
110,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
111,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
112,1,Mononeuropathy multiplex,Mononeuropathies,Peripheral neuropathies,Nerv,N
113,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
113,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
113,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
113,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
113,5,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
114,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
115,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
116,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
116,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
116,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
117,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
117,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
118,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
119,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
119,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,1,Crystal urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
120,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
120,3,Urinary sediment present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
121,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
121,2,Antiviral drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
121,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
122,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
122,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
122,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
122,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
123,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
123,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
124,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
124,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
124,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
124,4,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
124,5,Headache,Headaches NEC,Headaches,Nerv,N
124,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
124,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
125,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
126,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
126,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
126,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
127,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
127,2,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
128,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
129,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
129,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
130,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
131,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
131,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
131,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
132,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
133,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
134,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
134,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
135,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
136,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
136,2,Viral load,Virus identification and serology,Microbiology and serology investigations,Inv,N
137,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
137,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
138,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
138,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
140,1,Mitochondrial toxicity,Cell metabolism disorders NEC,Metabolism disorders NEC,Metab,N
141,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
141,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
141,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
142,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
142,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
143,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
143,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
143,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
143,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
144,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
145,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
145,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
146,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
147,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
147,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
148,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
149,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
149,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
150,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
150,2,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
150,3,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
151,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
152,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
152,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
152,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
152,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
153,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
153,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
154,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
154,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
154,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
155,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
156,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
158,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
158,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
158,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
158,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
158,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
159,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
160,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
161,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
162,1,Acute hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
162,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
162,3,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
163,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
164,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
164,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
166,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
166,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
167,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
168,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
168,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
169,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
171,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
172,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
172,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
172,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
173,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
174,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
176,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
176,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
177,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
177,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
177,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
177,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
177,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,7,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
177,8,HIV associated nephropathy,Retroviral infections,Viral infectious disorders,Infec,N
177,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
177,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
177,11,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
177,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
177,13,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
177,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,15,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
177,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
177,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
177,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
177,19,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
177,20,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
177,21,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
178,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
178,3,Migraine,Migraine headaches,Headaches,Nerv,N
178,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,5,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
179,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
180,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
181,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
182,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
182,2,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
183,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
184,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
185,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
186,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
186,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
187,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
187,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
188,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
188,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
189,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
189,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
189,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
189,4,Vesicoureteric reflux,Bladder reflux conditions,Bladder and bladder neck disorders (excl calculi),Renal,N
190,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
191,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
191,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
191,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
192,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
192,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
192,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
193,1,Waist circumference increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
194,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
194,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
195,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
195,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
195,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
196,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
197,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
197,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
198,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
198,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
198,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
198,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
198,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
198,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
198,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
199,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
199,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
199,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
199,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
199,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
201,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
201,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
201,3,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
201,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
202,1,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,Y
202,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
203,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
204,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
205,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
206,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
207,1,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
207,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
208,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
209,1,Headache,Headaches NEC,Headaches,Nerv,N
209,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
210,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
210,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
211,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
211,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
211,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
212,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
212,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
212,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
212,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
212,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
213,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
216,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
216,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
217,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
218,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
219,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
219,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
219,5,Waist circumference increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
220,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
221,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
222,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
223,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
223,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
224,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
225,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
225,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
227,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
228,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,Y
229,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
230,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
231,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
231,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
231,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
231,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
232,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
232,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
232,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
232,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
232,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
232,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
233,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
233,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
233,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
233,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
233,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
233,8,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
234,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
234,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
235,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,3,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
236,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
236,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
236,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
236,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
236,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
236,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
237,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
238,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
239,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
239,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
240,1,Immune reconstitution inflammatory syndrome associated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
241,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
241,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
241,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
242,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
243,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
243,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
244,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
245,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
246,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
247,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
247,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
248,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
249,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
250,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
251,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
251,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
251,3,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
252,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
252,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,5,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
253,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
254,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
254,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
254,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
254,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
255,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
255,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
256,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
257,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
258,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
259,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
260,1,Decreased eye contact,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
260,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
260,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
260,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
260,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
260,6,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
260,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
261,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
261,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
262,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
262,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
262,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
263,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
263,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
264,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
265,1,Delirium tremens,Deliria,Deliria (incl confusion),Psych,N
265,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
265,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
265,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
266,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
266,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
267,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
268,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
269,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
269,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
270,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
271,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
272,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
272,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
272,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
273,1,Amniotic band syndrome,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
273,2,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
273,3,Neonatal aspiration,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
273,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
273,5,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
273,6,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
273,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
274,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
274,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
275,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
275,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
275,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
275,5,Viral load decreased,Virus identification and serology,Microbiology and serology investigations,Inv,N
276,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
277,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
277,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
277,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
278,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
278,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
278,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
279,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
279,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
279,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
281,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
281,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
281,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
281,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
281,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
282,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
283,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
284,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
285,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
286,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
287,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
287,2,Penile blister,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
288,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
289,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
289,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
290,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
291,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
291,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
292,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
293,1,Headache,Headaches NEC,Headaches,Nerv,N
293,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
294,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
294,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
295,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
296,1,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
296,2,Cerebral ventricle dilatation,Structural brain disorders NEC,Structural brain disorders,Nerv,N
296,3,Congenital musculoskeletal disorder of skull,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
296,4,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
296,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
296,6,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
297,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
297,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
297,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
298,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
298,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
298,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
298,4,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
298,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
298,6,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
298,7,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
298,8,Twin pregnancy,Multiple pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
298,9,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
299,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
300,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
301,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
302,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
302,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
302,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
302,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
303,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
303,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,4,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
303,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
303,6,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
303,7,Headache,Headaches NEC,Headaches,Nerv,N
303,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,9,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
303,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
303,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
303,12,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
303,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
303,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
304,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
304,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
305,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
305,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
305,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
306,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
306,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
306,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
307,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
307,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
308,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
308,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
310,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
310,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
310,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
311,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
313,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
314,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
315,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
316,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
317,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
317,2,Placenta praevia,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
318,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
319,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
319,2,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
320,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
320,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
321,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
322,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
323,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,1,Blood HIV RNA,Virus identification and serology,Microbiology and serology investigations,Inv,N
324,2,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
324,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
324,4,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
324,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
324,6,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
324,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
325,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
326,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
326,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
326,3,Headache,Headaches NEC,Headaches,Nerv,N
326,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
327,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
328,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
328,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
328,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
328,4,Headache,Headaches NEC,Headaches,Nerv,N
328,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
328,6,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
328,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
329,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
329,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
329,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
329,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
329,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
329,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
330,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
330,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
330,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
330,5,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
330,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
330,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
330,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
332,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
333,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
333,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
333,3,Headache,Headaches NEC,Headaches,Nerv,N
333,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
333,5,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
333,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
333,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
333,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
333,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
334,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
334,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
334,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
334,4,Headache,Headaches NEC,Headaches,Nerv,N
334,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
334,6,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
335,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
336,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
337,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
339,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
340,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
341,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
342,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
343,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
344,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
344,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
345,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
346,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
347,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
348,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
349,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
350,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
351,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
352,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
353,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
353,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
354,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
356,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
356,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
356,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
357,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
357,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
358,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
358,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
358,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
358,5,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
358,6,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
358,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
358,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
358,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
358,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
358,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
358,12,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
358,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
359,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
360,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
361,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
361,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
362,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
362,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
363,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
364,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
364,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
365,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
366,1,Headache,Headaches NEC,Headaches,Nerv,N
366,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
366,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
367,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
367,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
368,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
368,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
369,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
369,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
370,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
370,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
371,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
372,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
372,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
373,1,Hepatic haemorrhage,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
373,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
374,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
374,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
374,3,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
375,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
375,2,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
376,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
376,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
376,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
376,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
377,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
377,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
377,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
377,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
378,1,Motor neurone disease,Motor neurone diseases,Neuromuscular disorders,Nerv,N
379,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
379,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
379,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
380,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
380,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
380,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
380,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
381,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
381,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
381,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
382,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
383,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
384,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
385,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
386,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
387,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
388,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
388,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
388,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
388,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
388,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
388,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
388,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
388,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
388,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,10,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
388,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
389,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
390,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
390,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
391,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
391,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
391,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
392,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
392,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
393,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
393,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
393,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
394,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
394,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
395,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
395,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
396,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
396,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
397,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
397,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
398,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
399,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
400,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
400,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
401,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
402,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
402,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
402,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
402,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
402,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
403,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
403,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
404,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
404,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
404,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
405,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
406,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
407,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
407,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
408,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
408,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
408,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
408,4,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
408,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
408,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
408,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
408,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
409,2,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
409,3,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
410,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
410,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
411,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
411,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
411,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
411,4,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
412,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
413,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
414,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
415,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
415,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
416,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
416,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
417,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
418,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
419,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
420,1,Acute hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
421,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
421,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
422,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
423,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
423,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
424,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
425,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
425,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
426,2,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
426,3,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
426,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
426,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
426,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
426,7,Glucocorticoids increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
426,8,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
426,9,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
426,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
427,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
427,2,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
428,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
429,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
429,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
429,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
430,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
431,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
431,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
431,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
432,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
432,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
433,1,Amniotic band syndrome,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
433,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
433,3,Limb reduction defect,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
434,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
434,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
435,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
435,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
436,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
436,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
437,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
437,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
438,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
438,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
439,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
439,2,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
440,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
441,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
441,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
442,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
442,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
442,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
443,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
443,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
443,3,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
443,4,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
443,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
443,6,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
443,7,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
443,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
443,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
443,10,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
443,11,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
443,12,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
443,13,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
443,14,Keloid scar,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
443,15,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
443,16,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
443,17,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
443,18,Myalgia,Muscle pains,Muscle disorders,Musc,N
443,19,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
443,20,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
443,21,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
443,22,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
443,23,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,24,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
444,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
444,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
445,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
445,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
445,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
445,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
446,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
447,1,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
447,2,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
447,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
447,4,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
448,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
449,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
449,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
449,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
450,1,Urine electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
451,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
451,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
452,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
453,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
454,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
455,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
456,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
456,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
456,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
456,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
456,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
457,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
458,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
459,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
459,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
459,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
459,4,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
459,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
459,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
460,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,2,Headache,Headaches NEC,Headaches,Nerv,N
460,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
460,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
461,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
462,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
462,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
462,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
462,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
462,5,Headache,Headaches NEC,Headaches,Nerv,N
462,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
462,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
462,8,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
462,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
462,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
463,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
463,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
464,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
464,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
464,3,Foetal growth abnormality,Foetal growth complications,Foetal complications,Preg,N
464,4,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
464,5,Gastroschisis,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
465,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
466,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
466,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
466,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
467,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
467,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
467,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
468,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
468,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
469,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
469,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
470,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
470,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
471,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
471,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
471,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
472,1,Tongue neoplasm,Lip and oral cavity neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
473,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
474,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
475,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
476,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
476,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
476,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
476,4,Ultrasound foetal abnormal,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
477,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
478,2,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
479,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
480,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
480,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
481,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
481,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
481,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
482,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
483,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
484,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
485,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
486,1,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
487,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
488,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
489,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
489,2,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
491,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
492,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
493,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
494,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
495,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
496,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
497,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
497,2,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
497,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
497,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
497,5,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
497,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
497,7,Headache,Headaches NEC,Headaches,Nerv,N
497,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
497,9,Menopause,Age related issues,Age related factors,SocCi,N
497,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
497,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
497,12,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
498,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
498,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
499,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
499,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
500,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
500,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
501,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
501,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
501,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
502,1,Fibrous histiocytoma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
502,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
502,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
502,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
503,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
504,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
504,2,Headache,Headaches NEC,Headaches,Nerv,N
505,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
506,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
507,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
507,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
508,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
508,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
509,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
510,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
511,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
512,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
513,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
514,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
514,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
515,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
516,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
516,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
517,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
518,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
518,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
518,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
518,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
519,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
520,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
520,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
520,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
520,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
521,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
522,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
523,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
523,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
524,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
524,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
525,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
525,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
527,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
528,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
528,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
528,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
529,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
530,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
530,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
530,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
531,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
531,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
531,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
532,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
533,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
533,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
533,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
534,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
534,2,Cervical vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
535,1,Cardiac infection,Cardiac infections,Infections - pathogen unspecified,Infec,N
536,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
536,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
536,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
537,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
538,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
538,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
538,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
538,4,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
538,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
539,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
540,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
541,1,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
541,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
541,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
541,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
542,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
543,1,Auditory disorder,Hearing disorders NEC,Hearing disorders,Ear,N
543,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
543,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
544,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
544,2,Headache,Headaches NEC,Headaches,Nerv,N
544,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
545,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
546,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
547,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
548,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
549,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
550,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
552,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
552,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
553,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
554,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
554,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
555,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
555,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
556,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
556,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
557,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
558,1,Lip discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
558,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
558,3,Lipoedema,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
558,4,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
558,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
558,6,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
558,7,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
558,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
558,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
558,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
559,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
559,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
560,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
561,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
562,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
562,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
562,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
563,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
563,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
564,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
565,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
565,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
565,3,Disability,Disability issues,Lifestyle issues,SocCi,N
566,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
566,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
566,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
567,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
567,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
567,4,Headache,Headaches NEC,Headaches,Nerv,N
567,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
567,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
568,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
568,2,Product size issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
569,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
570,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
571,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
571,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
572,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
573,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
574,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
575,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
576,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
576,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
576,3,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
577,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
578,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
579,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
581,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
582,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
582,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
583,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
583,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
584,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
584,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
585,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
586,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
586,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
587,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
587,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
588,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
589,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
589,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,1,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
592,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
593,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
594,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
595,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
596,1,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
597,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
597,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
597,3,Myopathy,Myopathies,Muscle disorders,Musc,N
598,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
598,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
600,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
601,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
601,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
602,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
603,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
603,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
604,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
605,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
606,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
607,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
607,2,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
607,3,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
607,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
607,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
607,6,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
607,7,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
608,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
608,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
609,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
609,2,Renal fusion anomaly,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
610,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
610,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
610,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
610,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
611,1,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
612,1,Glucocorticoid deficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
612,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
613,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
613,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
613,3,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
613,4,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
613,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
613,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
613,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
614,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
614,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
614,3,Drug clearance decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
614,4,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
614,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
615,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
616,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
618,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
618,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
618,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
618,4,Headache,Headaches NEC,Headaches,Nerv,N
618,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
618,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
618,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
619,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
620,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
621,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
622,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
623,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
623,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
625,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
625,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
626,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
626,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
627,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
629,3,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
629,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,5,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
630,1,Headache,Headaches NEC,Headaches,Nerv,N
630,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
631,1,Headache,Headaches NEC,Headaches,Nerv,N
631,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
632,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
633,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
633,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
634,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
635,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
636,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
637,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
638,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
639,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
639,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
639,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
639,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
640,1,Learning disorder,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
641,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
642,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
642,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
643,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
644,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
644,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
645,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
646,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
647,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
648,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
649,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
649,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
649,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
649,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
650,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
650,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
650,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
650,4,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
651,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
651,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
651,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
652,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
652,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
653,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
654,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
655,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
655,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
655,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
655,4,Headache,Headaches NEC,Headaches,Nerv,N
655,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
655,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
655,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
655,8,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
655,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
655,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
655,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
656,1,Headache,Headaches NEC,Headaches,Nerv,N
656,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
656,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
658,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
658,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
658,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,5,Headache,Headaches NEC,Headaches,Nerv,N
658,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
658,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
658,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
658,9,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
658,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
658,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
658,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
659,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
660,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
661,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
661,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
661,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
661,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
661,5,Headache,Headaches NEC,Headaches,Nerv,N
661,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
661,7,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
661,8,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
661,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
661,10,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
661,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
661,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
661,13,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
661,14,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
661,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
661,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
662,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
663,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
663,2,Congenital intestinal malformation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
663,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
663,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
663,5,Foetal growth abnormality,Foetal growth complications,Foetal complications,Preg,N
663,6,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
663,7,Gastroschisis,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
663,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
663,9,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
664,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
664,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,3,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
664,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
664,5,Headache,Headaches NEC,Headaches,Nerv,N
664,6,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
664,7,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
664,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
664,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
664,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
664,11,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
664,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
665,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
666,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
667,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
668,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
668,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
669,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
670,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
670,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
671,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
671,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
671,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
671,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
672,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
672,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
672,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
673,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
673,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
673,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
673,4,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
674,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
674,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
675,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
676,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
677,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
678,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
679,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
680,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
681,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
682,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
683,1,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
684,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
685,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
686,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
686,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
686,3,Disability,Disability issues,Lifestyle issues,SocCi,N
687,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
687,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
687,3,Headache,Headaches NEC,Headaches,Nerv,N
687,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
687,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
688,1,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
689,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
690,1,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
691,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
691,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
692,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
693,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
694,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
695,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
696,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
697,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
698,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
699,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
700,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
701,1,HIV viraemia,Retroviral infections,Viral infectious disorders,Infec,N
701,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
701,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
702,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
702,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
703,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
704,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
704,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
705,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
706,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
706,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
707,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
708,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
708,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
709,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
710,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
710,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
711,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
711,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
712,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
712,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
713,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
713,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
713,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
713,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
714,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
714,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
714,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
715,1,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
715,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
715,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
716,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
716,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
716,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
716,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
717,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
717,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
717,3,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
717,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
718,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
718,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
719,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
719,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
720,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
720,2,Migraine,Migraine headaches,Headaches,Nerv,N
720,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
721,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
721,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
722,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
722,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
723,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
724,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
724,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
724,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
725,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
726,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
727,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
728,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
729,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
730,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
730,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
731,1,Fat tissue decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
731,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
732,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
733,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
733,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
734,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
734,3,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
734,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
735,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
735,3,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
735,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
736,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
737,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
738,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
738,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
739,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
740,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
740,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
740,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
740,4,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
740,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
740,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
741,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
742,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
743,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
743,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
744,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
745,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
745,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
745,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
746,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
747,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
748,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
749,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
750,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
